Skip to content
DataLookout
Menu

NCT06489782

Developing a Novel Human Laboratory Paradigm for AUD Medication Screening

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 4 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Aug 31, 2026 to Aug 31, 2027
    • Eligibility criteria expanded, about 15 words
    • Study description revised
  2. Minor Primary and study completion dates pushed to Aug 31, 2026v5
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 15, 2024 to Nov 1, 2024
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Alcohol consumption
Timeframe: 120 minutes

Arms and interventions

Model 1Experimental

Model 1 examines the impact of alcohol cues and alcohol availability on latency to start drinking and amount consumed of a 0.12 g/dL dose of alcohol during a 2-hour ad-libitum period.

Model 2Experimental

Model 2 examines the impact of alcohol cues and alcohol availability and a priming dose of alcohol (.04 g/dL) on latency to start drinking and amount consumed of a 0.12 g/dL dose of alcohol during a 2-hour ad-libitum period.

Other: Model 1, Model 2

Sites

1 site in 1 country

  • Yale UniversityNew Haven, Connecticut, United States